{"description":"\u539f\u8457 \u80ba\u708e\uff1a\u7d4c\u53e3Lefamulin vs Moxifloxacin \uff08JAMA 2019;322(17):1661-1671\uff09 The LEAP 2 Randomized Clinical Trial \u2605lefamulin\u306f\u30a2\u30a4\u30eb\u30e9\u30f3\u30c9\u30fbNebriva Therapeutics\u793e\u306e\u65b0\u898f\u6297\u83cc\u85ac\u3002 \u26052019\u5e748\u6708\u306bFDA\u304c\u627f\u8a8d \u2605\u5546\u54c1\u540d\u300cXenleta\u300d\u3002150 mg\u9759\u6ce8\u88fd\u5264\u3068600 mg\u9320\u3042\u308a\u3002 \u2605\u80ba\u708e\u7403\u83cc\u3001MSSA\u3001\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u687f\u83cc\u3001\u30ec\u30b8\u30aa\u30cd\u30e9\u3001\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u3001\u30af\u30e9\u30df\u30c9\u30d5\u30a3\u30e9\u306a\u3069\u306b\u6709\u52b9\u3068\u3002\u30ad\u30ce\u30ed\u30f3\u306b\u8fd1\u3044\uff1f \u80cc\u666f \u25cf\u5e02\u4e2d\u80ba\u708e\u306b\u5bfe\u3059\u308b\u65b0\u898f\u6297\u83cc\u85ac\u304c\u6c42\u3081\u3089\u308c\u3066\u3044\u308b\u3002\u8010\u6027\u83cc\u3084\u3001\u73fe\u5728\u306e\u6cbb\u7642\u85ac\u306b\u3088\u308b\u526f\u4f5c\u2026","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fr-mtakagi.hatenadiary.jp%2Fentry%2F2019%2F12%2F25%2F115330\" title=\"\u7d4c\u53e3lefamulin\u306e\u80ba\u708e\u306b\u5bfe\u3059\u308b\u52b9\u679c\uff08\u539f\u8457\uff09 - MED INFO\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","width":"100%","blog_url":"https://r-mtakagi.hatenadiary.jp/","provider_url":"https://hatena.blog","provider_name":"Hatena Blog","author_name":"r_freestyle","published":"2019-12-25 11:53:30","url":"https://r-mtakagi.hatenadiary.jp/entry/2019/12/25/115330","type":"rich","image_url":null,"title":"\u7d4c\u53e3lefamulin\u306e\u80ba\u708e\u306b\u5bfe\u3059\u308b\u52b9\u679c\uff08\u539f\u8457\uff09","height":"190","blog_title":"MED INFO","version":"1.0","author_url":"https://blog.hatena.ne.jp/r_freestyle/","categories":["Journal\u2015\u539f\u8457","\u611f\u67d3\u75c7"]}